VivoSim Labs, Inc. (VIVS) Stock
Healthcare · Biotechnology · Member of Other US Stocks
VivoSim Labs, Inc. (VIVS) closed at USD 0.16 on 2026-10-14, a change of -93 % over the past year, with a market capitalization of USD 2.84M.
VivoSim Labs, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 0.16 |
| 2026-10-13 | 0.17 |
| 2026-10-12 | 0.17 |
| 2026-10-09 | 0.18 |
| 2026-10-08 | 0.18 |
| 2026-10-07 | 0.19 |
| 2026-10-06 | 0.20 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
VivoSim Labs, Inc. key figures
- Previous close
- USD 0.16 (2026-10-14)
- 1-year change
- -93 %
- Market cap
- USD 2.84M
- Enterprise value
- USD 1.19M
- P/E ratio (trailing)
- -0.04
- P/E ratio (forward)
- n/a
- EPS (trailing)
- -4.29
- EPS (forward)
- n/a
- PEG ratio
- n/a
- Price to book
- -0.23
- Revenue growth
- -51.4 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.78
- Employees
- 15
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About VivoSim Labs, Inc.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and build functional 3D human tissues through its proprietary technologies that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for VivoSim Labs, Inc. and compare it with other stocks.
Analyze VIVSAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell VivoSim Labs, Inc. shares.